Previous Page Table of Contents Next Page


APPENDIX V: PROPOSED DRAFT MAXIMUM RESIDUE LIMITS FOR VETERINARY DRUGS ADVANCED TO STEP 5

Chlortetracycline/Oxytetracycline/Tetracycline

ADI:

0-30 µg/kg body weight (1995) Group ADI for chlortetracycline, oxytetracycline and tetracycline

Residue Definition:

Parent drugs, singly or in combination.


Species

Tissue

MRL

(µg/kg)


Step

JECFA

CCRVDF

Fish

muscle

200

T

1/

5

50


Giant prawn

muscle

200


1/2/

5

50


1/ Applies only to oxytetracycline.
2/ Penaeus monodon.
Cyfluthrin

ADI:

0-20 µg/kg body weight (1997)

Residue Definition:

Cyfluthrin


Species

Tissue

MRL

(µg/kg)

Step

JECFA

CCRVDF

cattle

muscle

20


5

48


cattle

liver

20


5

48


cattle

kidney

20


5

48


cattle

fat

200


5

48


cattle

milk

40

(µg/l)

5

48



Danofloxacin

ADI:

0-20 µg/kg body weight (1997)

Residue Definition:

Danofloxacin.


Species

Tissue

MRL

(µg/kg)

Step

JECFA

CCRVDF

cattle

muscle

200


5

48


pig

muscle

100


5

48


chicken

muscle

200


5

48


cattle

liver

400


5

48


pig

liver

50


5

48


chicken

liver

400


5

48


cattle

kidney

400


5

48


pig

kidney

200


5

48


chicken

kidney

400


5

48


cattle

fat

100


5

48


pig

fat

100


5

48


chicken

fat

100

1/

5

48


1/ Fat/skin in normal proportion.
Keys for List of MRLs for Veterinary Drugs

ADI

Acceptable Daily Intake (expressed in micrograms/kilogram body weight)

Tissue

Muscle, Liver, Kidney, Fat, Fat/Skin, Milk or Egg

MRL

Maximum Residue Limit (unless noted otherwise, expressed in micrograms/kilogram)

Step

Step of the MRL at the time of consideration by the CCRVDF or Year of its adoption by the Codex Alimentarius Commission

JECFA

Meeting number of the Joint FAO/WHO Expert Committee on Food Additives where the substance was evaluated and/or MRL recommended/considered

CCRVDF

Session number of the CCRVDF where the MRL was considered and Appendix number of its report where the MRL is contained.


Eprinomectin

ADI:

0-10 µg/kg body weight (1998)

Residue Definition:

Eprinomectin B1a


Species

Tissue

MRL

(µg/kg)

Step

JECFA

CCRVDF

cattle

muscle

100


5

50


cattle

liver

2000


5

50


cattle

kidney

300


5

50


cattle

fat

250


5

50


cattle

milk

20

(µg/l)

5

50



Flumequine

ADI:

0-30 µg/kg body weight (1997)

Residue Definition:

Flumequine


Species

Tissue

MRL

(µg/kg)


Step

JECFA

CCRVDF

cattle

muscle

500



5

42, 48


pig

muscle

500

T


5

42, 48


sheep

muscle

500

T


5

42, 48


chicken

muscle

500

T


5

42, 48


trout

muscle

500

T

1/

5

42, 48


cattle

liver

1000



5

42, 48


pig

liver

1000

T


5

42, 48


sheep

liver

1000

T


5

42, 48


chicken

liver

1000

T


5

42, 48


cattle

kidney

3000



5

42, 48


pig

kidney

3000

T


5

42, 48


sheep

kidney

3000

T


5

42, 48


chicken

kidney

3000

T


5

48


cattle

fat

1000



5

48


pig

fat

1000

T


5

48


sheep

fat

1000

T


5

48


chicken

fat

1000

T


5

48


1/ Muscle/skin in normal proportion.
Imidocarb

ADI:

0-10 µg/kg body weight (1998)

Residue Definition:

Imidocarb.


Species

Tissue

MRL

(µg/kg)

Step

JECFA

CCRVDF

cattle

muscle

300

T

5

50


cattle

liver

2000

T

5

50


cattle

kidney

1500

T

5

50


cattle

fat

50

T

5

50


cattle

milk

50

(µg/l) T

5

50



Sarafloxacin

ADI:

0-0.3 µg/kg body weight (1998)

Residue Definition:

Sarafloxacin


Species

Tissue

MRL

(µg/kg)

Step

JECFA

CCRVDF

chicken

muscle

10


5

50


turkey

muscle

10


5

50


chicken

liver

80


5

50


turkey

liver

80


5

50


chicken

kidney

80


5

50


turkey

kidney

80


5

50


chicken

fat

20


5

50


turkey

fat

20


5

50



Previous Page Top of Page Next Page